Christopher Seder

Christopher Seder is a Professor in the Department of Cardiovascular and Thoracic Surgery at Rush University Medical College. His academic role includes leadership in surgical oncology, thoracic surgery, and clinical research. He is actively involved with the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database, contributing to outcome analyses and quality improvement initiatives. His research focuses on surgical outcomes, biomarker development for cancer diagnosis/prognosis, and innovations in thoracic surgical techniques.

Dr. Seder's research interests span lung cancer screening, esophageal and thoracic malignancies, surgical complications analysis, and translational research in biomarkers (e.g., angiogenesis proteins, autoantibody panels). He has collaborated extensively with institutions globally to improve surgical practices and patient outcomes. Notable contributions include studies on prolonged air leak scoring, robotic vs. thoracoscopic resections, and the impact of comorbidities (e.g., sarcopenia) on surgical outcomes.

His publications demonstrate a strong emphasis on clinical research, with a focus on translating laboratory findings into surgical practice. Recent work includes biomarker panels for pulmonary nodule identification, analysis of cannabis use in pneumothorax recurrence, and gender-specific outcomes in lung cancer patients. Dr. Seder also maintains active involvement in surgical training and education, emphasizing evidence-based practices and simulation-based training for thoracic surgeons.